Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection
Sentaro Kusuhara, Makoto Nakamura Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe 650-0017, JapanCorrespondence: Sentaro KusuharaDepartment of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo...
Guardado en:
Autores principales: | Kusuhara S, Nakamura M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8336d666cdd4c7b9e28933c1afc0e0a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ocular hypotensive effects of a Rho-associated protein kinase inhibitor in rabbits
por: Kamaruddin MI, et al.
Publicado: (2017) -
The Baerveldt Glaucoma Drainage Device: Efficacy, Safety, and Place in Therapy
por: Poelman HJ, et al.
Publicado: (2020) -
Outcome of phacoemulsification combined with excisional goniotomy using the Kahook Dual Blade in severe glaucoma patients at 6 months
por: Hirabayashi MT, et al.
Publicado: (2019) -
A multicenter retrospective comparison of goniotomy versus trabecular bypass device implantation in glaucoma patients undergoing cataract extraction
por: Dorairaj SK, et al.
Publicado: (2018) -
Comparison of clinical effects of two latanoprost 0.005% solutions (Xalatan® and Arulatan®) in primary open-angle glaucoma or ocular hypertensive patients: a randomized clinical trial
por: Brant Fernandes RA, et al.
Publicado: (2019)